Key result
Contactless rPPG tracks pulse rate with ~1 bpm mean error versus ECG in cardiovascular patients.
Why the study?
Cardiovascular disease is the leading cause of global mortality, driving demand for continuous, unobtrusive monitoring solutions like contactless remote photoplethysmography.
Does remote photoplethysmography (rPPG) accurately measure pulse rate compared to ECG in adults with cardiovascular disease?
Does remote photoplethysmography (rPPG) accurately measure pulse rate compared to ECG in adults with cardiovascular disease?
Contactless remote photoplethysmography (rPPG) accurately measures pulse rate in patients with cardiovascular disease compared to standard ECG, offering a potential tool for unobtrusive remote monitoring.
Supports contactless monitoring feasibility in CVD; leaves open prospective validation before clinical use.
Background: Cardiovascular disease (CVD) is the leading cause of mortality worldwide, creating demand for continuous, unobtrusive monitoring solutions. This clinical validation evaluates the accuracy of remote photoplethysmography (rPPG), a contactless method using camera video, for measuring pulse rate (PR) in patients with CVD. Methods: We enrolled 50 adults with confirmed CVD at a clinical trial center. In a 6 min rested session, synchronized facial video (under controlled lighting), electrocardiogram (ECG), and photoplethysmography (PPG) signals were recorded. PR was derived from 25 s video segments using rPPG-enabled software and compared to ECG-derived PR via regression and Bland–Altman analysis. Results: Data from 47 participants (n = 817 samples) were analyzed. rPPG-derived PR showed strong agreement with ECG, with a mean absolute error of 1.061 bpm, root-mean-squared error of 2.845 bpm, and Pearson correlation of 0.962. Mixed-effects regression analyses (after 2% outlier removal, n = 782) indicated minimal influence from demographic, environmental, or CVD factors on accuracy. PPG-ECG discrepancies reflected inherent methodological differences. Conclusion: The rPPG method provides accurate, contactless PR monitoring in CVD patients, supporting its potential for remote patient monitoring and early deterioration detection. Future work will validate rPPG for irregular rhythms, additional vital signs, and diverse cohorts to strengthen clinical robustness for cardiometabolic risk assessment.
No takes yet. Share an insight, caveat, or question.
Chin et al. (2026) studied this question. rPPG contactless pulse rate monitoring in cardiovascular disease patients showed strong agreement with ECG, with mean absolute error 1.061 bpm and Pearson correlation 0.962.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: